TWD 31.05
(0.16%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -453.9 Million TWD | -0.7% |
2022 | -450.76 Million TWD | 1.92% |
2021 | -459.59 Million TWD | -26.11% |
2020 | -364.44 Million TWD | -6.5% |
2019 | -342.2 Million TWD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q1 | -450.56 Million TWD | 0.74% |
2024 Q2 | -442.57 Million TWD | 1.77% |
2023 Q4 | -453.9 Million TWD | -9.76% |
2023 FY | -453.9 Million TWD | -0.7% |
2023 Q1 | -452.43 Million TWD | 1.76% |
2023 Q2 | -452.18 Million TWD | 0.06% |
2023 Q3 | -413.54 Million TWD | 8.54% |
2022 Q4 | -460.56 Million TWD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Sagittarius Life Science Corp | -120.57 Million TWD | -276.465% |
Neith Corporation | -150.31 Million TWD | -201.977% |
TaiRx, Inc. | -147.86 Million TWD | -206.964% |
BioGend Therapeutics Co., Ltd. | -317.41 Million TWD | -42.999% |
Shine-On BioMedical Co.,Ltd. | -101.48 Million TWD | -347.258% |
Great Novel Therapeutics Biotech & Medicals | -165.17 Million TWD | -174.8% |
SYN-TECH Chem. & Pharm. Co., Ltd. | -264.16 Million TWD | -71.823% |
NeoCore Technology Co., Ltd. | -196.39 Million TWD | -131.116% |
GeneReach Biotechnology Corp. | 40.26 Million TWD | 1227.264% |
Genomics BioSci & Tech. Co.,Ltd. | 30.57 Million TWD | 1584.414% |
Visgeneer Inc. | 31.28 Million TWD | 1550.914% |
Sunmax Biotechnology Co., Ltd. | -680.6 Million TWD | 33.309% |
G&E Herbal Biotechnology Co., Ltd. | -134.25 Million TWD | -238.099% |
TaiwanJ Pharmaceuticals Co., Ltd. | -57.65 Million TWD | -687.235% |
Enimmune corporation | -314.15 Million TWD | -44.482% |
EirGenix Inc. | -4.58 Billion TWD | 90.107% |
BioLASCO Taiwan Co., Ltd. | -84.76 Million TWD | -435.498% |
Sunny Pharmtech Inc. | 120.87 Million TWD | 475.528% |
Feng Chi Biotech Corp. | -19.81 Million TWD | -2190.94% |
Lukas Biomedical Inc. | 50.75 Million TWD | 994.304% |
RBC Bioscience Corporation | 422.18 Million TWD | 207.513% |
BiOptic Inc. | 12.59 Million TWD | 3704.701% |
Anti-Microbial Savior BioteQ Co., Ltd | -77.04 Million TWD | -489.149% |
Syngen Biotech Co.,Ltd. | 314.87 Million TWD | 244.155% |
Mycenax Biotech Inc. | 207 Million TWD | 319.268% |
Medigen Vaccine Biologics Corporation | 621.53 Million TWD | 173.029% |
Bio Preventive Medicine Corp. | 31.8 Million TWD | 1526.967% |
TaiMed Biologics Inc. | 499.84 Million TWD | 190.808% |
GlycoNex Incorporation | -148.56 Million TWD | -205.521% |
Taiwan Advance Bio-Pharmaceutical Inc. | 137.99 Million TWD | 428.928% |
SynCore Biotechnology Co.,Ltd | -262.58 Million TWD | -72.862% |
Lin BioScience, Inc. | -3.21 Billion TWD | 85.896% |
BRIM Biotechnology, Inc. | -944.4 Million TWD | 51.938% |
VBI | -25.31 Million TWD | -1692.953% |
CHO Pharma, Inc. | -203.79 Million TWD | -122.729% |
Advagene Biopharma Co., Ltd. | -64.32 Million TWD | -605.686% |
NaviFUS Corp. | -123.12 Million TWD | -268.641% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 74.05 Million TWD | 712.961% |
Sinew Pharma Inc. | -160.34 Million TWD | -183.08% |
Andros Pharmaceuticals Co.,Ltd | -241.89 Million TWD | -87.647% |
Greenyn Biotechnology Co., Ltd | -337.37 Million TWD | -34.54% |
Lumosa Therapeutics Co., Ltd. | -412.63 Million TWD | -10.001% |
AP Biosciences Inc | -196.52 Million TWD | -130.961% |
Medigen Biotechnology Corp. | 688.73 Million TWD | 165.904% |
3D Global Biotech Inc. | -11.43 Million TWD | -3868.733% |
Pharmosa Biopharm Inc. | -829.69 Million TWD | 45.292% |
Intech Biopharm Corporation | 1.35 Billion TWD | 133.441% |
Oneness Biotech Co., Ltd. | -414.87 Million TWD | -9.407% |
Eusol Biotech Co.,Ltd. | -209.33 Million TWD | -116.828% |
TWi Biotechnology, Inc. | -143.86 Million TWD | -215.511% |
Ever Supreme Bio Technology Co., Ltd | -330.54 Million TWD | -37.321% |
TCI GENE Inc. | -689.25 Million TWD | 34.145% |
MegaPro Biomedical Co., Ltd | -118.93 Million TWD | -281.631% |
Senhwa Biosciences, Inc. | -1.3 Billion TWD | 65.33% |
Taiwan Bio Therapeutics Co., Ltd | 20.48 Million TWD | 2316.004% |
NatureWise Biotech & Medicals Corporation | -101.87 Million TWD | -345.572% |
PharmaEngine, Inc. | -860.8 Million TWD | 47.27% |
Savior Lifetec Corporation | -812.54 Million TWD | 44.138% |
TaiGen Biopharmaceuticals Holdings Limited | -299.96 Million TWD | -51.317% |
OBI Pharma, Inc. | -398.22 Million TWD | -13.982% |
Meribank Biotech Co., Ltd | -365.41 Million TWD | -24.215% |
Acepodia, Inc. | -6.02 Billion TWD | 92.46% |
Caliway Biopharmaceuticals Co., Ltd. | -3.4 Billion TWD | 86.657% |